FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:1059-1060 March 8, 2007 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Animation Perspective by Maisel, W. H. Perspective by Farb, A. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Lagerqvist, B. Related Article by Mauri, L. Related Article by Kastrati, A. Related Article by Maisel, W. H. Related Article by Farb, A. Related Article by Spaulding, C. Related Article by Stone, G. W. PubMed Citation

In this issue of the Journal, we publish five Original Articles and two Perspective articles on the subject of drug-eluting coronary stents.^{1,2,3,4,5,6,7} Our motivation is the recent concern that the implantation of drug-eluting stents, as compared with bare-metal stents, may be associated with a small increased risk of late stent thrombosis, a potentially fatal complication (Figure 1). At a meeting of the Circulatory System Devices Advisory Panel of the Food and Drug Administration (FDA) on December 7 and 8, 2006, presentations were made on virtually every aspect of this complex clinical problem.⁸ In order to inform the medical . . . [Full Text of this Article]

Source Information

This article (10.1056/NEJMe068306) was published at www.nejm.org on February 12, 2007.

This article has been cited by other articles:

• Ormiston, J. A., Webster, M. W.I., Schwartz, R. S., Gladding, P., Stewart, J. T., Kay, I. P., Ruygrok, P. N., Hatrick, R. (2009). Feasibility, Safety, and Efficacy of a Novel Polymeric Pimecrolimus-Eluting Stent: Traditional Pre-Clinical Safety End Points Failed to Predict 6-Month Clinical Angiographic Results. J Am Coll Cardiol Intv 2: 1017-1024 [Abstract] [Full Text]  
• Bhatt, D. L. (2009). Prasugrel in Clinical Practice. NEJM 361: 940-942 [Full Text]  
• Herdeg, C., Gohring-Frischholz, K., Haase, K. K., Geisler, T., Zurn, C., Hartmann, U., Wohrle, J., Nusser, T., Dippon, J., May, A. E., Gawaz, M. (2009). Catheter-Based Delivery of Fluid Paclitaxel for Prevention of Restenosis in Native Coronary Artery Lesions After Stent Implantation. Circ Cardiovasc Interv 2: 294-301 [Abstract] [Full Text]  
• To, A. C.Y., Armstrong, G., Zeng, I., Webster, M. W.I. (2009). Noncardiac Surgery and Bleeding After Percutaneous Coronary Intervention. Circ Cardiovasc Interv 2: 213-221 [Abstract] [Full Text]  
• Carlsson, J., James, S. K., Lindback, J., Schersten, F., Nilsson, T., Stenestrand, U., Lagerqvist, B., for the SCAAR (Swedish Coronary Angiography and An, (2009). Outcome of Drug-Eluting Versus Bare-Metal Stenting Used According to On- and Off-Label Criteria. J Am Coll Cardiol 53: 1389-1398 [Abstract] [Full Text]  
• Samady, H., McDaniel, M., Veledar, E., De Bruyne, B., Pijls, N. H., Fearon, W. F., Vaccarino, V. (2009). Baseline Fractional Flow Reserve and Stent Diameter Predict Optimal Post-Stent Fractional Flow Reserve and Major Adverse Cardiac Events After Bare-Metal Stent Deployment. J Am Coll Cardiol Intv 2: 357-363 [Abstract] [Full Text]  
• (2009). Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes.. Circ Cardiovasc Interv 2: 35-42  
• Kelbaek, H., Terkelsen, C. J., Helqvist, S., Lassen, J. F., Clemmensen, P., Klovgaard, L., Kaltoft, A., Engstrom, T., Botker, H. E., Saunamaki, K., Krusell, L. R., Jorgensen, E., Hansen, H.-H. T., Christiansen, E. H., Ravkilde, J., Kober, L., Kofoed, K. F., Thuesen, L. (2008). Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial.. J Am Coll Cardiol 51: 899-905 [Abstract] [Full Text]  
• Applegate, R. J., Sacrinty, M. T., Kutcher, M. A., Santos, R. M., Gandhi, S. K., Baki, T. T., Little, W. C. (2008). "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents.. J Am Coll Cardiol 51: 607-614 [Abstract] [Full Text]  
• Egashira, K., Nakano, K., Ohtani, K., Funakoshi, K., Zhao, G., Ihara, Y., Koga, J.-i., Kimura, S., Tominaga, R., Sunagawa, K. (2007). Local Delivery of Anti-Monocyte Chemoattractant Protein-1 by Gene-Eluting Stents Attenuates In-Stent Stenosis in Rabbits and Monkeys. Arterioscler. Thromb. Vasc. Bio. 27: 2563-2568 [Abstract] [Full Text]  
• Holmes, D. R. Jr, Kereiakes, D. J., Laskey, W. K., Colombo, A., Ellis, S. G., Henry, T. D., Popma, J. J., Serruys, P. W.J.C., Kimura, T., Williams, D. O., Windecker, S., Krucoff, M. W. (2007). Thrombosis and Drug-Eluting Stents: An Objective Appraisal. J Am Coll Cardiol 50: 109-118 [Abstract] [Full Text]  
• (2007). JournalScan. Heart 93: 890-892 [Full Text]  
• Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., Chaitman, B. R., Shaw, L., Gosselin, G., Nawaz, S., Title, L. M., Gau, G., Blaustein, A. S., Booth, D. C., Bates, E. R., Spertus, J. A., Berman, D. S., Mancini, G.B. J., Weintraub, W. S., the COURAGE Trial Research Group, (2007). Optimal Medical Therapy with or without PCI for Stable Coronary Disease. NEJM 356: 1503-1516 [Abstract] [Full Text]  
• (2007). Latest Findings on Stents. JWatch General 2007: 1-1 [Full Text]